Skip to main content

Advertisement

Figure 1 | Critical Care

Figure 1

From: Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study

Figure 1

Pharmacokinetics and pharmacodynamics of danaparoid during continuous infusion after a loading dose. Course of the levels of anti-Xa activity (left panel) and prothrombin fragment F1+2 (right panel) during the first 24 hours of treatment with a continuous danaparoid infusion of 100 anti-Xa-U/hour after a loading dose of 3,500 anti-Xa-U. Data represent median and range.

Back to article page